Results 211 to 220 of about 531,069 (346)

Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP‐4 as Diagnostic and Predictive Biomarkers

open access: yeseJHaem, Volume 7, Issue 1, February 2026.
ABSTRACT Background Paediatric classical Hodgkin lymphoma (cHL) is the most common malignancy in adolescents, and despite excellent survival, a subset of patients experiences treatment failure or severe long‐term toxicity, underscoring the need for improved risk stratification. Early response assessment is particularly important, as it guides decisions
Gustav Hedberg   +6 more
wiley   +1 more source

Aberrant lipid metabolism renders an aggressive behavior of T-lymphoblastic lymphoma in a MASH model. [PDF]

open access: yesOncogene
Guo W   +8 more
europepmc   +1 more source

A National Audit of Current UK Practice on the Use of Anti‐Emetics for Chemotherapy‐Induced Nausea and Vomiting in Children

open access: yesPediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT This UK national audit aimed to assess adherence to evidence‐based chemotherapy‐induced nausea and vomiting (CINV) guidelines for children with cancer, which emphasise treatment emetogenicity assessment, symptom monitoring and appropriate antiemetic use.
Eloise Neumann   +5 more
wiley   +1 more source

Supplementary Figure S17 from A CpG Methylation Classifier to Predict Relapse in Adults with T-Cell Lymphoblastic Lymphoma

open access: gold, 2023
Xiao-Peng Tian   +53 more
openalex   +1 more source

Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry

open access: yes
American Journal of Hematology, Volume 101, Issue 2, Page 365-375, February 2026.
Jon Salmanton‐García   +95 more
wiley   +1 more source

Early Toxicity in Childhood Acute Lymphoblastic Leukemia: A Comparison of NOPHO ALL2008 and ALLTogether Protocols in Sweden

open access: yesPediatric Blood &Cancer, Volume 73, Issue 2, February 2026.
ABSTRACT Background The European ALLTogether protocol for childhood acute lymphoblastic leukemia, initiated in Sweden 2019, introduced earlier asparaginase during induction, dexamethasone instead of prednisone for all patients, and omitted anthracyclines from low‐risk induction to reduce treatment‐related toxicity.
Johannes Fermér   +11 more
wiley   +1 more source

Risk Factors Influencing Survival in T-Cell Lymphoblastic Lymphoma and T-Cell Acute Lymphoblastic Leukemia. [PDF]

open access: yesCancer Med
Kim TY   +12 more
europepmc   +1 more source

From Genomic and Epigenomic Maps to Medicines in Adult T‐Cell Leukemia/Lymphoma

open access: yesCancer Science, Volume 117, Issue 2, Page 289-296, February 2026.
ABSTRACT Adult T‐cell leukemia/lymphoma (ATL) is an aggressive and refractory hematologic malignancy that is caused by human T‐cell leukemia virus type‐1 (HTLV‐1) retrovirus. ATL results from a combination of viral latency and the accumulation of abnormalities throughout the genome, epigenome, transcriptome, and signaling pathways.
Kako Suzuki, Makoto Yamagishi
wiley   +1 more source

Paediatric lymphoblastic lymphoma: a national review of 20 years of clinical and biological data in Ireland. [PDF]

open access: yesAnn Hematol
Trinquand A   +9 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy